Publications by authors named "Motoki Ochi"

Claim this Profile
P
Preclinical Metabolism and Disposition of TP0473292, a Novel Oral Prodrug of the Potent Metabotropic Glutamate 2/3 Receptor Antagonist TP0178894 for the Treatment of Depression.
Shoko Inatani, Motoki Ochi, Kohnosuke Kinoshita, Jun-Ichi Yamaguchi, Hiromi Endo

Drug Metab Dispos· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ozoralizumab, a Humanized Anti-TNFα NANOBODY Compound, Exhibits Efficacy Not Only at the Onset of Arthritis in a Human TNF Transgenic Mouse but Also During Secondary Failure of Administration of an Anti-TNFα IgG.
Chihiro Ishiwatari-Ogata, Masanao Kyuuma, Hitoshi Ogata, Machi Yamakawa, Katsuya Iwata, Motoki Ochi

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bottom-up physiologically based pharmacokinetic modelling for predicting the human pharmacokinetic profiles of the ester prodrug MGS0274 and its active metabolite MGS0008, a metabotropic glutamate 2/3 receptor agonist.
Motoki Ochi, Kohnosuke Kinoshita, Jun-Ichi Yamaguchi, Hiromi Endo

Xenobiotica· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability.
Hiroki Urabe, Naoki Miyakoshi, Norikazu Ohtake, Akiko Nozoe, Motoki Ochi

Eur J Med Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical disposition of MGS0274 besylate, a prodrug of a potent group II metabotropic glutamate receptor agonist MGS0008 for the treatment of schizophrenia.
Kohnosuke Kinoshita, Motoki Ochi, Katsuya Iwata, Misako Fukasawa, Jun-Ichi Yamaguchi

Pharmacol Res Perspect· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis